Anne Mannila

428 total citations
8 papers, 326 citations indexed

About

Anne Mannila is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Anne Mannila has authored 8 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in Anne Mannila's work include Drug Transport and Resistance Mechanisms (3 papers), Anesthesia and Pain Management (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Anne Mannila is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Anesthesia and Pain Management (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Anne Mannila collaborates with scholars based in Finland and Australia. Anne Mannila's co-authors include Jarkko Rautio, Tomi Järvinen, Jouko Savolainen, Krista Laine, Jukka Leppänen, Tapio Nevalainen, Mikko Gynther, Jarmo Ropponen, Marko Lehtonen and Jouko Vepsäläinen and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmaceutical Sciences and Clinical Pharmacokinetics.

In The Last Decade

Anne Mannila

8 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Mannila Finland 7 142 109 62 49 43 8 326
Beverley Hammond United Kingdom 9 145 1.0× 89 0.8× 96 1.5× 23 0.5× 67 1.6× 11 418
Xingxiang Peng United States 10 239 1.7× 193 1.8× 40 0.6× 15 0.3× 48 1.1× 11 495
Joseph Rager United States 5 124 0.9× 138 1.3× 50 0.8× 8 0.2× 19 0.4× 9 339
Linda Metzner Germany 10 203 1.4× 243 2.2× 35 0.6× 136 2.8× 49 1.1× 11 464
Jasminka Dragovic United States 7 105 0.7× 114 1.0× 132 2.1× 21 0.4× 52 1.2× 7 338
Kazunobu Aoyama Japan 14 199 1.4× 83 0.8× 73 1.2× 23 0.5× 49 1.1× 19 409
Johanna Huttunen Finland 14 262 1.8× 216 2.0× 84 1.4× 300 6.1× 24 0.6× 23 554
Hélène Chapy France 13 98 0.7× 164 1.5× 61 1.0× 31 0.6× 11 0.3× 16 347
Eric Burak United States 9 144 1.0× 57 0.5× 68 1.1× 11 0.2× 25 0.6× 22 354
Didier M. Lambert Belgium 9 137 1.0× 30 0.3× 64 1.0× 15 0.3× 17 0.4× 9 364

Countries citing papers authored by Anne Mannila

Since Specialization
Citations

This map shows the geographic impact of Anne Mannila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Mannila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Mannila more than expected).

Fields of papers citing papers by Anne Mannila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Mannila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Mannila. The network helps show where Anne Mannila may publish in the future.

Co-authorship network of co-authors of Anne Mannila

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Mannila. A scholar is included among the top collaborators of Anne Mannila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Mannila. Anne Mannila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Huttunen, Kristiina M., Anne Mannila, Krista Laine, et al.. (2009). The First Bioreversible Prodrug of Metformin with Improved Lipophilicity and Enhanced Intestinal Absorption. Journal of Medicinal Chemistry. 52(14). 4142–4148. 57 indexed citations
3.
Kumpulainen, Hanna, Tomi Järvinen, Anne Mannila, et al.. (2008). Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol. European Journal of Pharmaceutical Sciences. 34(2-3). 110–117. 23 indexed citations
4.
Gynther, Mikko, Krista Laine, Jarmo Ropponen, et al.. (2008). Large Neutral Amino Acid Transporter Enables Brain Drug Delivery via Prodrugs. Journal of Medicinal Chemistry. 51(4). 932–936. 125 indexed citations
5.
Jalkanen, Aaro J., Katja A. Puttonen, Jarkko I. Venäläinen, et al.. (2006). Beneficial Effect of Prolyl Oligopeptidase Inhibition on Spatial Memory in Young but Not in Old Scopolamine‐Treated Rats. Basic & Clinical Pharmacology & Toxicology. 100(2). 132–138. 41 indexed citations
6.
Mannila, Anne, Marko Lehtonen, M. Heikkinen, et al.. (2006). Plasma and Cerebrospinal Fluid Concentrations of Indomethacin in Children After Intravenous Administration. The Journal of Clinical Pharmacology. 47(1). 94–100. 19 indexed citations
7.
Mannila, Anne, Merja Kokki, M. Heikkinen, et al.. (2006). Cerebrospinal Fluid Distribution of Ketoprofen after Intravenous Administration in Young Children. Clinical Pharmacokinetics. 45(7). 737–743. 24 indexed citations
8.
Mannila, Anne, Jarkko Rautio, Marko Lehtonen, Tomi Järvinen, & Jouko Savolainen. (2004). Inefficient central nervous system delivery limits the use of ibuprofen in neurodegenerative diseases. European Journal of Pharmaceutical Sciences. 24(1). 101–105. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026